WO2000078307A1 - Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate - Google Patents

Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate Download PDF

Info

Publication number
WO2000078307A1
WO2000078307A1 PCT/KR1999/000327 KR9900327W WO0078307A1 WO 2000078307 A1 WO2000078307 A1 WO 2000078307A1 KR 9900327 W KR9900327 W KR 9900327W WO 0078307 A1 WO0078307 A1 WO 0078307A1
Authority
WO
WIPO (PCT)
Prior art keywords
ranitidine
sucralfate
coated
bismuth subcitrate
coating agent
Prior art date
Application number
PCT/KR1999/000327
Other languages
English (en)
French (fr)
Inventor
Young-Hyo Yoo
Hak-Hyung Kim
Jong-Wan Lee
Joon-Woo Park
Byung-Soo Jang
Original Assignee
Daewoong Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19570891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2000078307(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daewoong Pharmaceutical Co., Ltd. filed Critical Daewoong Pharmaceutical Co., Ltd.
Priority to AU46551/99A priority Critical patent/AU4655199A/en
Priority to CNB998167568A priority patent/CN1173698C/zh
Priority to KR10-2001-7016389A priority patent/KR100453179B1/ko
Priority to PCT/KR1999/000327 priority patent/WO2000078307A1/en
Publication of WO2000078307A1 publication Critical patent/WO2000078307A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
PCT/KR1999/000327 1999-06-21 1999-06-21 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate WO2000078307A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU46551/99A AU4655199A (en) 1999-06-21 1999-06-21 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate
CNB998167568A CN1173698C (zh) 1999-06-21 1999-06-21 包含包衣的雷尼替丁、碱式柠檬酸铋和硫糖铝的对胃肠障碍具有治疗作用的可口服给药的药物制剂
KR10-2001-7016389A KR100453179B1 (ko) 1999-06-21 1999-06-21 피복된 라니티딘, 비스마스 서브시트레이트 및수크랄페이트를 함유하는 경구용 위장질환 치료용 약제조성물
PCT/KR1999/000327 WO2000078307A1 (en) 1999-06-21 1999-06-21 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR1999/000327 WO2000078307A1 (en) 1999-06-21 1999-06-21 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate

Publications (1)

Publication Number Publication Date
WO2000078307A1 true WO2000078307A1 (en) 2000-12-28

Family

ID=19570891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR1999/000327 WO2000078307A1 (en) 1999-06-21 1999-06-21 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate

Country Status (4)

Country Link
KR (1) KR100453179B1 (ko)
CN (1) CN1173698C (ko)
AU (1) AU4655199A (ko)
WO (1) WO2000078307A1 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103702A2 (en) * 2005-04-01 2006-10-05 Mccullough Ricky W Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium
WO2016122226A2 (en) 2015-01-30 2016-08-04 Daewoong Pharmaceutical Co., Ltd. A pharmaceutical composition for treating gastrointestinal diseases

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101507717B (zh) * 2009-03-13 2013-01-23 沈阳药科大学 一种治疗消化性溃疡的复方片剂及其制备方法
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
KR101801064B1 (ko) 2015-07-20 2017-11-27 안국약품 주식회사 위장질환 치료용 삼중층 정제
KR101794529B1 (ko) * 2016-06-14 2017-11-07 주식회사 인트로바이오파마 위장질환 치료용 필름코팅정제, 및 이의 제조방법
KR20230156474A (ko) 2022-05-06 2023-11-14 에니솔루션 주식회사 위장질환 치료용 복합정제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403048A2 (en) * 1989-06-14 1990-12-19 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
JPH10109942A (ja) * 1996-08-13 1998-04-28 Takeda Chem Ind Ltd 医 薬

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403048A2 (en) * 1989-06-14 1990-12-19 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
JPH10109942A (ja) * 1996-08-13 1998-04-28 Takeda Chem Ind Ltd 医 薬

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199827, Derwent World Patents Index; AN 1998-306092 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103702A2 (en) * 2005-04-01 2006-10-05 Mccullough Ricky W Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium
WO2006103702A3 (en) * 2005-04-01 2006-12-21 Ricky W Mccullough Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium
WO2016122226A2 (en) 2015-01-30 2016-08-04 Daewoong Pharmaceutical Co., Ltd. A pharmaceutical composition for treating gastrointestinal diseases
CN107205947A (zh) * 2015-01-30 2017-09-26 株式会社大熊制药 用于治疗胃肠道疾病的药物组合物
JP2018503672A (ja) * 2015-01-30 2018-02-08 デウォン ファーマシューティカル カンパニー リミテッド 胃腸疾患治療用医薬組成物
EP3250199A4 (en) * 2015-01-30 2018-08-08 Daewoong Pharmaceutical Co., Ltd. A pharmaceutical composition for treating gastrointestinal diseases

Also Published As

Publication number Publication date
CN1173698C (zh) 2004-11-03
AU4655199A (en) 2001-01-09
KR100453179B1 (ko) 2004-10-15
CN1354660A (zh) 2002-06-19
KR20020031342A (ko) 2002-05-01

Similar Documents

Publication Publication Date Title
AU2019268052B2 (en) Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
KR100389602B1 (ko) 소화관하부용출형피부캅셀제제
JP3725542B2 (ja) ピコサルフェート剤形
AU603568B2 (en) Pharmaceutical formulations of acid labile substances for oral use
CA2081709C (en) Controlled release pharmaceutical compositions
CA2702356C (en) Pharmaceutical formulation comprising a proton pump inhibitor for the treatment of gastrointestinal conditions independent of food intake
RU2201754C2 (ru) Фармацевтический состав, способ его получения, способ лечения психотических состояний и гиперактивности
MXPA05001538A (es) Distribuidor de tipo manguito de endoscopio.
JP3633936B2 (ja) センナ剤形
JP2000514051A (ja) ベンズイミダゾール誘導体を活性成分とする経口投与用の安定な薬剤形およびその製造方法
BRPI0615014A2 (pt) composição farmacêutica sólida compreendendo 1-(4-cloroanilino)-4-(4-piridilmetil)ftalazina e um modificador de ph e uso da mesma
WO2000078307A1 (en) Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate
CN109890372B (zh) 含埃索美拉唑的复合胶囊及其制备方法
WO2004062552A2 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
AU668267B2 (en) Method for preventing and treating disturbances of intestinal mucous membrane
MXPA05004338A (es) Composiciones de liberacion sostenida que contienen alfuzosin.
WO2007054565A2 (en) New stabilized galenic formulations comprising lansoprazole and their preparation
JPH05139964A (ja) 塩酸メキシレチン腸溶性製剤
WO2004084867A1 (fr) Compositions pharmaceutiques adaptees au colon de medicaments ameliorant la motilite du tractus gastro-intestinal, et leur utilisation
JP2002518330A (ja) 処置方法
US20140322313A1 (en) Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist
WO2023278300A1 (en) Solid dosage form of n-1-pyrrolidine-n-5-(3-trifluoromethoxy)phenyl biguanide and uses thereof
US20100105738A1 (en) Extended release formulations of a proton pump inhibitor
MXPA06007779A (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
MXPA00005895A (en) Oral pharmaceutical pulsed release dosage form

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1200101227

Country of ref document: VN

Ref document number: 99816756.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1020017016389

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020017016389

Country of ref document: KR

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: 1020017016389

Country of ref document: KR